Gleb S. Ivanov

1.1k total citations · 1 hit paper
11 papers, 855 citations indexed

About

Gleb S. Ivanov is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Gleb S. Ivanov has authored 11 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Surgery. Recurrent topics in Gleb S. Ivanov's work include Cancer-related Molecular Pathways (3 papers), DNA and Nucleic Acid Chemistry (2 papers) and Epigenetics and DNA Methylation (2 papers). Gleb S. Ivanov is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), DNA and Nucleic Acid Chemistry (2 papers) and Epigenetics and DNA Methylation (2 papers). Gleb S. Ivanov collaborates with scholars based in United States, Russia and United Kingdom. Gleb S. Ivanov's co-authors include Julia K. Kurash, Danny Reinberg, Nickolai A. Barlev, Kristine McKinney, Bing Xiao, Carol Prives, J. Wilson, N. Justin, S.J. Gamblin and Paul Tempst and has published in prestigious journals such as Nature, Molecular and Cellular Biology and Gene.

In The Last Decade

Gleb S. Ivanov

10 papers receiving 847 citations

Hit Papers

Regulation of p53 activit... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gleb S. Ivanov United States 5 770 246 64 47 29 11 855
Uta-Maria Bauer Germany 6 945 1.2× 218 0.9× 62 1.0× 69 1.5× 13 0.4× 6 1.0k
Alina Castell Sweden 12 629 0.8× 258 1.0× 93 1.5× 49 1.0× 17 0.6× 17 755
Juliana Callaghan United Kingdom 4 627 0.8× 118 0.5× 84 1.3× 41 0.9× 23 0.8× 5 785
Elodie Hatchi France 9 706 0.9× 231 0.9× 101 1.6× 74 1.6× 23 0.8× 9 788
Rohrmoser Michaela Germany 12 838 1.1× 209 0.8× 95 1.5× 35 0.7× 9 0.3× 12 967
Alessandra Ianari United States 7 517 0.7× 299 1.2× 91 1.4× 39 0.8× 29 1.0× 9 592
Miaw-Sheue Tsai United States 21 996 1.3× 339 1.4× 147 2.3× 106 2.3× 24 0.8× 31 1.1k
Luis A. Martinez United States 10 601 0.8× 275 1.1× 218 3.4× 67 1.4× 45 1.6× 13 755
Thau Ho United States 12 338 0.4× 262 1.1× 183 2.9× 38 0.8× 34 1.2× 16 511
Gruber-Eber Anita Germany 9 736 1.0× 181 0.7× 80 1.3× 29 0.6× 8 0.3× 9 823

Countries citing papers authored by Gleb S. Ivanov

Since Specialization
Citations

This map shows the geographic impact of Gleb S. Ivanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gleb S. Ivanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gleb S. Ivanov more than expected).

Fields of papers citing papers by Gleb S. Ivanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gleb S. Ivanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gleb S. Ivanov. The network helps show where Gleb S. Ivanov may publish in the future.

Co-authorship network of co-authors of Gleb S. Ivanov

This figure shows the co-authorship network connecting the top 25 collaborators of Gleb S. Ivanov. A scholar is included among the top collaborators of Gleb S. Ivanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gleb S. Ivanov. Gleb S. Ivanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ivanov, Gleb S., et al.. (2022). Artificial genetic polymers against human pathologies. Biology Direct. 17(1). 39–39. 4 indexed citations
2.
Ivanov, Gleb S., et al.. (2020). Activating Effect of 3‐Benzylidene Oxindoles on AMPK: From Computer Simulation to High‐Content Screening. ChemMedChem. 15(24). 2521–2529. 11 indexed citations
3.
Krasavin, Mikhail, Dmitry Dar’in, Olga Bakulina, et al.. (2018). Design, in silico prioritization and biological profiling of apoptosis-inducing lactams amenable by the Castagnoli-Cushman reaction. Bioorganic & Medicinal Chemistry. 26(9). 2651–2673. 12 indexed citations
4.
Fedorova, Olga, et al.. (2015). [NEGATIVE REGULATORS OF TUMOR SUPPRESSOR P53 IN THE CONTEXT OF ANTICANCER THERAPY].. PubMed. 57(12). 847–54. 2 indexed citations
5.
Ivanov, Gleb S., et al.. (2009). Aleukemic leukemia cutis. 2 indexed citations
6.
Ivanov, Gleb S., Т. А. Иванова, Julia K. Kurash, et al.. (2007). Methylation-Acetylation Interplay Activates p53 in Response to DNA Damage. Molecular and Cellular Biology. 27(19). 6756–6769. 158 indexed citations
7.
Saha, Shamol, Michael Buratovich, Heath D. Schmidt, et al.. (2006). Transcription Factor IIA τ Is Associated with Undifferentiated Cells and Its Gene Expression Is Repressed in Primary Neurons at the Chromatin Level In Vivo. Stem Cells and Development. 15(2). 175–190. 3 indexed citations
8.
Chuikov, Sergei, Julia K. Kurash, J. Wilson, et al.. (2004). Regulation of p53 activity through lysine methylation. Nature. 432(7015). 353–360. 656 indexed citations breakdown →
9.
Ivanov, Gleb S., et al.. (2003). Sp and GATA factors are critical for Apolipoprotein AI downstream enhancer activity in human HepG2 cells. Gene. 323. 31–42. 4 indexed citations
10.
Ivanov, Gleb S., et al.. (1988). [Structure of illexine I2 and its complexes with DNA].. PubMed. 21(6). 1590–9. 3 indexed citations
11.
Ivanov, Gleb S., et al.. (1983). [Comparative study of synthetic peptide fragments of histones H2B].. PubMed. 28(1). 35–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026